Back to search

The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β

Data up to Jan 2025

Published2005
Citations306
References27

Total Citations Per Year

Abstract

References (27)

Epithelial–mesenchymal transitions in tumour progression

2002 • 6,431 citations

Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus

2003 • 5,611 citations

TGF-β signalling from cell membrane to nucleus through SMAD proteins

1997 • 3,650 citations

TGF-β signaling in tumor suppression and cancer progression

2001 • 2,235 citations

Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene

1998 • 1,763 citations

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter

2002 • 849 citations

Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation

2001 • 828 citations

Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis

2000 • 823 citations

Two major Smad pathways in TGF‐β superfamily signalling

2002 • 647 citations

TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

1998 • 630 citations

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

2002 • 609 citations

Development of TGF-β signalling inhibitors for cancer therapy

2004 • 536 citations

TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells

1999 • 419 citations

Endogenous TGF-β signaling suppresses maturation of osteoblastic mesenchymal cells

2004 • 327 citations

Cooperative Inhibition of Bone Morphogenetic Protein Signaling by Smurf1 and Inhibitory Smads

2003 • 316 citations

Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)

2002 • 306 citations

The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development

2001 • 306 citations

Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors

1998 • 281 citations

Smad6 Is a Smad1/5-induced Smad Inhibitor

2000 • 277 citations

Targeting the TGFβ signaling network in human neoplasia

2003 • 245 citations

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

2003 • 231 citations

TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell–derived endothelial cells

2003 • 169 citations

Regulation of TGF‐β signaling and its roles in progression of tumors

2003 • 163 citations

A role for Id in the regulation of TGF-β-induced epithelial–mesenchymal transdifferentiation

2004 • 144 citations

A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.

1999 • 116 citations

Chromosomal Region Maintenance 1 (CRM1)-dependent Nuclear Export of Smad Ubiquitin Regulatory Factor 1 (Smurf1) Is Essential for Negative Regulation of Transforming Growth Factor-β Signaling by Smad7

2003 • 94 citations

Clinical significance of the expression of activin A in esophageal carcinoma

2003 • 47 citations

Cited By (0)

No citing papers found in database

The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal… (2005) – Cancer Science | Metascience Observatory Explorer